560
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Successful treatment of recalcitrant generalized pustular psoriasis of pregnancy with spesolimab

, , , &
Article: 2334791 | Received 15 Feb 2024, Accepted 20 Mar 2024, Published online: 02 Apr 2024

References

  • Babuna Kobaner G, Polat Ekinci A. Infliximab for the treatment of recalcitrant generalized pustular psoriasis of pregnancy: report of a challenging case. Dermatol Ther. 2020;33(4):e13571. doi: 10.1111/dth.13571.
  • Seishima M, Fujii K, Mizutani Y. Generalized pustular psoriasis in pregnancy: current and future treatments. Am J Clin Dermatol. 2022;23(5):661–671. doi: 10.1007/s40257-022-00698-9.
  • Murrieta-Coxca JM, Rodríguez-Martínez S, Cancino-Diaz ME, et al. IL-36 cytokines: regulators of inflammatory responses and their emerging role in immunology of reproduction. Int J Mol Sci. 2019;20(7):1649. doi: 10.3390/ijms20071649.
  • Johnston A, Xing X, Wolterink L, et al. IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis. J Allergy Clin Immunol. 2017;140(1):109–120. doi: 10.1016/j.jaci.2016.08.056.
  • Kodali N, Blanchard I, Kunamneni S, et al. Current management of generalized pustular psoriasis. Exp Dermatol. 2023;32(8):1204–1218. doi: 10.1111/exd.14765.
  • Baum P, Visvanathan S, Garcet S, et al. Pustular psoriasis: molecular pathways and effects of spesolimab in generalized pustular psoriasis. J Allergy Clin Immunol. 2022;149(4):1402–1412. doi: 10.1016/j.jaci.2021.09.035.
  • Murrieta-Coxca JM, Gutiérrez-Samudio RN, El-Shorafa HM, et al. Role of IL-36 cytokines in the regulation of angiogenesis potential of trophoblast cells. Int J Mol Sci. 2020;22(1):285. doi: 10.3390/ijms22010285.
  • Bachelez H, Choon SE, Marrakchi S, et al. Trial of spesolimab for generalized pustular psoriasis. N Engl J Med. 2021;385(26):2431–2440. doi: 10.1056/NEJMoa2111563.
  • Iznardo H, Puig L. Exploring the role of IL-36 cytokines as a new target in psoriatic disease. Int J Mol Sci. 2021;22(9):4344. doi: 10.3390/ijms22094344.